Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Radiopharmaceutical market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.2% during the forecast period.
This report presents the market size and development trends by detailing the Radiopharmaceutical market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Radiopharmaceutical market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Radiopharmaceutical industry and will help you to build a panoramic view of the industrial development.
Radiopharmaceutical Market, By Type:
SPECT Radioisotopes
PET Radioisotopes
Other Diagnostic Radioisotopes
Therapeutic Radioisotopes
Radiopharmaceutical Market, By Application:
Oncology
Cardiology
Other
Some of the leading players are as follows:
GE Healthcare
Mallinckrodt
Bracco Imaging
Eli Lilly
Lantheus
Jubilant Pharma
SIEMENS
Triad Isotopes
Bayer
Nordion
Navidea
IBA Group
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Radiopharmaceutical Market: Technology Type Analysis
-
4.1 Radiopharmaceutical Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Radiopharmaceutical Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 SPECT Radioisotopes
4.3.2 PET Radioisotopes
4.3.3 Other Diagnostic Radioisotopes
4.3.4 Therapeutic Radioisotopes
5 Radiopharmaceutical Market: Product Analysis
-
5.1 Radiopharmaceutical Product Market Share Analysis, 2018 & 2026
-
5.2 Radiopharmaceutical Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Radiopharmaceutical Market: Application Analysis
-
6.1 Radiopharmaceutical Application Market Share Analysis, 2018 & 2026
-
6.2 Radiopharmaceutical Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Oncology
6.3.2 Cardiology
6.3.3 Other
7 Radiopharmaceutical Market: Regional Analysis
-
7.1 Radiopharmaceutical Regional Market Share Analysis, 2018 & 2026
-
7.2 Radiopharmaceutical Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 GE Healthcare
9.1.1 GE Healthcare Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Mallinckrodt
9.2.1 Mallinckrodt Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Bracco Imaging
9.3.1 Bracco Imaging Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Eli Lilly
9.4.1 Eli Lilly Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Lantheus
9.5.1 Lantheus Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Jubilant Pharma
9.6.1 Jubilant Pharma Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 SIEMENS
9.7.1 SIEMENS Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Triad Isotopes
9.8.1 Triad Isotopes Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Bayer
9.9.1 Bayer Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Nordion
9.10.1 Nordion Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Navidea
9.11.1 Navidea Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 IBA Group
9.12.1 IBA Group Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
The List of Tables and Figures (Totals 70 Figures and 122 Tables)
Figure SPECT Radioisotopes Radiopharmaceutical market, 2015 - 2026 (USD Million)
Figure PET Radioisotopes Radiopharmaceutical market, 2015 - 2026 (USD Million)
Figure Other Diagnostic Radioisotopes Radiopharmaceutical market, 2015 - 2026 (USD Million)
Figure Therapeutic Radioisotopes Radiopharmaceutical market, 2015 - 2026 (USD Million)
Figure Oncology market, 2015 - 2026 (USD Million)
Figure Cardiology market, 2015 - 2026 (USD Million)
Figure Other market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Radiopharmaceutical market, by country, 2015 - 2026 (USD Million)
-
Table North America Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table North America Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table North America Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table Canada Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table Canada Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Europe Radiopharmaceutical market, by country, 2015 - 2026 (USD Million)
-
Table Europe Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table Europe Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table Europe Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table Germany Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table Germany Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table France Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table France Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table Italy Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table Italy Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table Spain Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table Spain Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Radiopharmaceutical market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table China Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table China Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table Japan Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table Japan Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table India Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table India Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Radiopharmaceutical market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table MEA Radiopharmaceutical market, by country, 2015 - 2026 (USD Million)
-
Table MEA Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table MEA Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table MEA Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Radiopharmaceutical market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Radiopharmaceutical market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Radiopharmaceutical market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table GE Healthcare Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mallinckrodt Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bracco Imaging Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Lantheus Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Jubilant Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table SIEMENS Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Triad Isotopes Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Nordion Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Navidea Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table IBA Group Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
